Four-Membered Azapalladacycles
Organometallics, Vol. 23, No. 6, 2004 1445
31P) ) 7.6 Hz, CH), 130.5 (d, J (13C-31P) ) 51.1 Hz, C PPh3),
130.6 (s, CH), 132.6 (s, CH), 134.8 (d, J (13C-31P) ) 12.6 Hz,
CH PPh3), 135.5 (s, C), 160.5 (s, C), one C not observed. 31P
NMR (CDCl3, 121.5 MHz): δ 35.7.
residue afforded palladacycle 8a . Yield: 37 mg, 72%. Mp: 86-
87 °C. IR (film): 1666, 1479, 1435 cm-1. 1H NMR (CDCl3, 300
MHz): δ 3.58 (d, J (1H-31P) ) 1.8 Hz, 6H), 7.23 (t, J ) 7.5 Hz,
1H), 7.29-7.45 (m, 10H), 7.58 (ddd, J ) 8.1, 7.5, and 1.5 Hz,
1H), 7.65 (d, J ) 7.5 Hz, 1H), 7.70-7.80 (m, 6H). 13C NMR
(CDCl3, 75.5 MHz): δ 54.3 (s, CH3), 120.4 (d, J (13C-31P) ) 2.8
Hz, CH), 125.4 (s, CH), 127.9 (d, J (13C-31P) ) 11 Hz, CH PPh3),
128.5 (s, CH), 130.1 (d, J (13C-31P) ) 2.2 Hz, CH PPh3), 132.5
(d, J (13C-31P) ) 50.1 Hz, C PPh3), 134.1 (s, CH), 134.7
(d, J (13C-31P) ) 12.1 Hz, CH PPh3), 140.8 (d, J (13C-31P) )
9.9 Hz, C), 156.7 (d, J (13C-31P) ) 2.5 Hz, C), 209.8 (d,
J (13C-31P) ) 14.3 Hz, C). 31P NMR (CDCl3, 121.5 MHz): δ
40.0. Anal. Calcd for C27H25INOPPd (643.78): C, 50.37; H, 3.91;
N, 2.18. Found: C, 50.25; H, 4.13; N, 2.03.
[P d {K2-C(O)C6H4N(Me)CH2P h -2}I(P P h 3)] (8b). Operat-
ing as in the preparation of 8a , starting from 4b (27 mg, 0.04
mmol), azapalladacycle 8b was obtained after chromatography
(SiO2, from hexane to 1:1 hexane-EtOAc). Yield: 18 mg, 64%.
Azapalladacycle 8b was crystallized from EtOAc. Mp: 140-
142 °C. 1H NMR (CDCl3, 300 MHz): δ 3.92 (d, J (1H-31P) )
1.8 Hz, 3H), 4.08 (dd, J ) 11.7 Hz and J (1H-31P) ) 6 Hz, 1H),
5.56 (d, J ) 11.7 Hz, 1H), 6.98-7.09 (m, 3H), 7.15-7.22 (m,
2H), 7.28-7.43 (m, 12H), 7.55-7.67 (m, 6H), 7.80 (d, J ) 8.1
Hz, 1H). 13C NMR (CDCl3, 75.5 MHz): δ 53.5 (s, CH3), 67.4 (s,
CH2), 121.5 (d, J (13C-31P) ) 2.5 Hz, CH), 124.9 (s, CH), 127.8
(d, J (13C-31P) ) 10.4 Hz, CH PPh3), 127.9 (s, CH), 128.4 (s,
CH), 128.6 (s, CH), 130.0 (d, J (13C-31P) ) 2.2 Hz, CH PPh3),
131.5 (s, CH), 132.5 (d, J (13C-31P) ) 49.5 Hz, C PPh3), 133.7
(s, CH), 134.5 (s, C), 134.7 (d, J (13C-31P) ) 11.6 Hz, CH PPh3),
142.9 (d, J (13C-31P) ) 9.9 Hz, C), 153.3 (d, J (13C-31P) ) 1.5
Hz, C), 207.6 (d, J (13C-31P) ) 14 Hz, C). 31P NMR (CDCl3,
121.5 MHz): δ 38.6.
[P d P h I(P NMe2)] (7a ).16 A solution of azapalladacycle 4a
(20 mg, 0.032 mmol) in THF (5 mL) was stirred at 110 °C in
a sealed tube for 36 h. The solvent was evaporated, and the
residue was purified by flash chromatography (SiO2, CH2Cl2)
to give palladium complex 7a as an 10:1 mixture of the
transP,I and cisP,I isomers. Yield: 11 mg, 55%. transP,I
isomer: 1H NMR (CDCl3, 400 MHz): δ 3.40 (s, 6H), 6.64-
6.74 (m, 3H), 6.94 (m, 2H), 7.28-7.39 (m, 10H), 7.42-7.48 (m,
2H), 7.59 (tt, J ) 8.4 and 1.2 Hz, 1H), 7.69 (dd, J ) 8.4 and
4.4 Hz, 1H). 13C NMR (CDCl3, 100.6 MHz): δ 53.8 (s, CH3),
122.5 (s, CH), 123.0 (d, J (13C-31P) ) 10 Hz, CH), 126.6 (d,
J (13C-31P) ) 1.5 Hz, CH), 128.4 (d, J (13C-31P) ) 6.1 Hz, CH),
128.7 (d, J (13C-31P) ) 10.7 Hz, CH), 129.1 (d, J (13C-31P) )
53.7 Hz, C), 130.9 (d, J (13C-31P) ) 3.1 Hz, CH), 131.1 (d,
J (13C-31P) ) 46.5 Hz, C), 133.2 (d, J (13C-31P) ) 12.3 Hz, CH),
133.3 (d, J (13C-31P) ) 1.5 Hz, CH), 134.4 (s, CH), 137.7 (d,
J (13C-31P) ) 4.6 Hz, CH), 138.7 (s, C), 159.5 (d, J (13C-31P) )
18.4 Hz, C). 31P NMR (CDCl3, 121.5 MHz): δ 23.7. cisP,I
isomer: 31P NMR (CDCl3, 121.5 MHz): δ 36.5.
[P d P h I{P N(Me)P r }] (7c).41 A solution of azapalladacycle
4c (25 mg, 0.039 mmol) in toluene (10 mL) was stirred at
110 °C in a sealed tube for 24 h. The solvent was evaporated,
and the residue was purified by flash chromatography (SiO2,
from hexane to 1:1 hexane-EtOAc). Elution with hexane-
EtOAc (4:1) afforded azapalladacycle 7c-transP,I. Yield: 8 mg,
32%. Elution with hexane-EtOAc (3:2) afforded azapallada-
cycle 7c-cisP,I. Yield: 2 mg, 8%. transP,I isomer: 1H NMR
(CDCl3, 400 MHz): δ 0.91 (t, J ) 7.2 Hz, 3H), 1.03 (m, 1H),
2.42 (m, 1H), 3.19 (td, J ) 11.6 and 4 Hz, 1H), 3.33 (s, 3H),
4.40 (td, J ) 11.6 and 4.8 Hz, 1H), 6.65-6.74 (m, 3H), 6.94
(m, 2H), 7.07-7.13 (m, 2H), 7.27-7.49 (m, 10H), 7.57-7.68
(m, 2H). 13C NMR (CDCl3, 100.6 MHz): δ 11.2 (s, CH3), 21.7
(s, CH2), 54.1 (s, CH3), 64.9 (s, CH2), 122.4 (s, CH), 122.9 (d,
J (13C-31P) ) 10 Hz, CH), 126.7 (s, CH), 128.4 (d, J (13C-31P)
) 6.1 Hz, CH), 128.5 (d, J (13C-31P) ) 10.8 Hz, CH), 128.8 (d,
J (13C-31P) ) 11.5 Hz, CH), 129.9 (d, J (13C-31P) ) 53 Hz, C),
130.7 (d, J (13C-31P) ) 3 Hz, CH), 131.0 (d, J (13C-31P) ) 3 Hz,
CH), 133.0 (d, J (13C-31P) ) 12.2 Hz, CH), 133.1 (d, J (13C-
31P) ) 50 Hz, C), 133.4 (d, J (13C-31P) ) 1.5 Hz, CH), 133.4
(d, J (13C-31P) ) 12.3 Hz, CH), 134.4 (s, CH), 137.7 (d,
J (13C-31P) ) 4.5 Hz, CH), 139.3 (d, J (13C-31P) ) 2.3 Hz, C),
157.3 (d, J (13C-31P) ) 18.4 Hz, C). 31P NMR (CDCl3, 121.5
MHz): δ 27.3. MS(FAB): m/z 1161 [2M+ + 2 - I], 1084
[2M+ + 2 - I - C6H5], 566 [M+ - C6H5], 516 [M+ - I], 439
[M+ - I - C6H5]. cisP,I isomer: 1H NMR (CDCl3, 400 MHz):
δ 0.87 (t, J ) 7.2 Hz, 3H), 0.98 (m, 1H), 2.45 (m, 1H), 3.31 (td,
J ) 12 and 4.4 Hz, 1H), 3.57 (s, 3H), 4.83 (td, J ) 12 and 4.8
Hz, 1H), 7.31 (m, 1H), 7.38 (m, 1H), 7.41-7.49 (m, 6H), 7.50-
7.57 (m, 3H), 7.61-7.70 (m, 3H), 7.75-7.85 (m, 5H). 13C NMR
(CDCl3, 100.6 MHz): δ 10.8 (s, CH3), 21.9 (s, CH2), 57.1
(s, CH3), 67.8 (s, CH2), 122.2 (d, J (13C-31P) ) 12.3 Hz, CH),
128.7 (d, J (13C-31P) ) 11.6 Hz, CH), 128.8 (d, J (13C-31P) )
12.2 Hz, CH), 129.7 (d, J (13C-31P) ) 5.3 Hz, CH), 130.3 (d,
J (13C-31P) ) 59 Hz, C), 131.8-132.1 (several CH), 134.0-134.5
(several CH), 157.9 (d, J (13C-31P) ) 17.6 Hz, C). 31P NMR
(CDCl3, 121.5 MHz): δ 40.6. MS(FAB): m/z 566 [M+ - C6H5],
439 [M+ - I - C6H5].
[P d {K2-C(O)C6H4N(Me)P r -2}I(P P h 3)] (8c). Operating as
in the preparation of 8a , starting from 4c (32 mg, 0.05 mmol)
and stirring the reaction mixture at room temperature for 41
h, azapalladacycle 8c was obtained after chromatography
(SiO2, from hexane to 1:1 hexane-EtOAc). Yield: 23 mg, 69%.
Azapalladacycle 8b was crystallized from dichloromethane. IR
1
(film): 1665, 1435, 1095 cm-1. H NMR (CDCl3, 300 MHz): δ
0.90 (t, J ) 7.2 Hz, 3H), 1.09 (m, 1H), 2.34 (m, 1H), 3.08 (m,
1H), 3.61 (d, J ) 1.5 Hz, 3H), 4.51 (td, J ) 12 and 4.5 Hz,
1H), 7.23 (m, 1H), 7.31-7.45 (m, 9H), 7.58-7.61 (m, 2H),
7.68-7.77 (m, 6H). 13C NMR (CDCl3, 75.5 MHz): δ 11.1
(s, CH3), 22.2 (s, CH2), 54.2 (s, CH3), 65.6 (s, CH2), 120.6 (d,
J (13C-31P) ) 3 Hz, CH), 125.2 (s, CH), 127.9 (d, J (13C-31P) )
11.1 Hz, CH PPh3), 128.5 (s, CH), 130.1 (d, J (13C-31P) ) 2 Hz,
CH PPh3), 132.7 (d, J (13C-31P) ) 49.7 Hz, C PPh3), 134.3 (s,
CH), 134.7 (d, J (13C-31P) ) 11.6 Hz, CH PPh3), 142.7 (d,
J (13C-31P) ) 9.7 Hz, C), 154.4 (d, J (13C-31P) ) 3 Hz, C), 209.4
(d, J (13C-31P) ) 14.2 Hz, C). 31P NMR (CDCl3, 121.5 MHz): δ
43.2. Anal. Calcd for C29H29INOPPd (671.85)‚3/4CH2Cl2: C,
48.58; H, 4.18; N, 1.90. Found: C, 48.18; H, 4.21; N, 1.77.
[P d {K2-CH(CO2Et)C6H4NMe2-2}I(P P h 3)] (9a ). To a solu-
tion of azapalladacycle 4a (30 mg, 0.05 mmol) in benzene (10
mL) was added ethyl diazoacetate (0.55 mmol, 1.1 mL of 0.5
M solution in benzene). The mixture was stirred at room
temperature for 24 h under argon, and the solvent was
evaporated. Chromatography (SiO2, from hexane to 4:1 hex-
ane-EtOAc) of the residue afforded palladacycle 9a , which was
crystallized from Et2O-EtOAc. Yield: 20 mg, 56%. Mp: 187-
188 °C. IR (film): 1681, 1436, 1146 cm-1 1H NMR (CDCl3,
.
300 MHz): δ 0.87 (t, J ) 7.2 Hz, 3H), 3.42 (d, J (1H-31P) ) 5.7
Hz, 3H), 3.42 (masked, 1H), 3.55 (s, 3H), 3.65 (dq, J ) 10.8
and 7.2 Hz, 1H), 4.01 (dq, J ) 10.8 and 7.2 Hz, 1H), 6.75 (dd,
J ) 7.5 and 1.2 Hz, 1H), 7.05 (td, J ) 7.5 and 1.2 Hz, 1H),
7.21 (ddd, J ) 8.1, 7.5, and 1.2 Hz, 1H), 7.35 (dd, J ) 8.1 and
1.2 Hz, 1H), 7.37-7.50 (m, 9H), 7.77-7.88 (m, 6H). 13C NMR
(CDCl3, 75.5 MHz): δ 13.9 (s, CH3), 51.6 (s, CH), 52.1 (s, CH3),
55.7 (s, CH3), 59.9 (s, CH2), 121.5 (s, CH), 127.4 (s, CH), 127.5
(s, CH), 127.8 (d, J (13C-31P) ) 10.6 Hz, CH PPh3), 129.0 (s,
CH), 130.5 (s, CH), 132.2 (d, J (13C-31P) ) 52.2 Hz, C PPh3),
[P d{K2-C(O)C6H4NMe2-2}I(P P h 3)] (8a). KOt-Bu (1.6 mmol,
1.6 mL of 1 M solution in tert-butyl alcohol) was added to
CHCl3 (10 mL). After 5 min at room temperature, a solution
of palladacycle 4a (49 mg, 0.08 mmol) in CHCl3 (5 mL) was
added dropwise. The mixture was stirred at room temperature
for 5 h under argon, and the solvent was evaporated. Chro-
matography (SiO2, from hexane to 1:1 hexane-EtOAc) of the
(41) PN(Me)Pr means N-methyl-N-propyl-2-(diphenylphosphanyl)-
aniline.